Jesslyn Kelsey
Family · Stanford, KYNPI 1346727112
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $585, 2.5 times the $237 reported in 2021.
Across 101 payments — averaging $15.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$252
- Lilly USA, LLC$142
- Agile Therapeutics, Inc.$141
- Evofem Biosciences, Inc.$133
- Biogen$122
- Shield Therapeutics Inc$94
- plus $704 from 18 others
What the payments were for
- Food & beverage$1,589100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $252 |
| Lilly USA, LLC | 11 | $142 |
| Agile Therapeutics, Inc. | 9 | $141 |
| Evofem Biosciences, Inc. | 15 | $133 |
| Biogen | 6 | $122 |
| Shield Therapeutics Inc | 1 | $94 |
| Mayne Pharma Commercial LLC | 7 | $89 |
| Vanda Pharmaceuticals Inc. | 4 | $72 |
| Astellas Pharma US Inc | 4 | $67 |
| Avion Pharmaceuticals | 4 | $65 |
| Therapeuticsmd, Inc. | 4 | $61 |
| Verona Pharma, Inc. | 2 | $49 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $45 |
| Myovant Sciences Inc. | 2 | $45 |
| GSK | 2 | $33 |
| Axonics, Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Bausch Health US, LLC | 1 | $21 |
| Novo Nordisk | 1 | $19 |
| Exeltis, USA Inc. | 1 | $17 |
| Bayer | 1 | $16 |
| Exact Sciences | 1 | $14 |
| Pfizer | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
How this compares
$1,589 in reported general payments places this provider in the 75th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MinivelleEstradiol | 13 | $3,047 |
| Metronidazole | 26 | $955 |
| Triamcinolone Acetonide | 12 | $120 |
| Fluconazole | 17 | $80 |
Paid to pharmacies, not to this prescriber.
Other family in Stanford
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
- Carrie Parrish NyekanBowling Green$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.